Team
Statistical Machine Learning and Modelling of Biological Systems
Thematic areas of research:
Image
![Image couverture equipe Thomas Walter](/sites/default/files/styles/header_sciences/public/medias/images/2021-07/couv_5.jpg?h=aabbdb8b&itok=DIKuZDIW)
To top
Team
THOMAS WALTER
Statistical Machine Learning and Modelling of Biological Systems
Members
Image
![](/sites/default/files/styles/membre_90x90/public/annuaire/220176-657c6d837f023.jpg?h=038a9462&itok=XjoWu2-U)
Key publications
All publications
-
Where Do We Stand in Regularization for Life Science Studies?Journal of Computational Biology
-
-
-
Spatial transcriptomics for respiratory research and medicineEuropean Respiratory Journal
-
Drug Target Identification with Machine Learning: How to Choose Negative ExamplesInternational Journal of Molecular Sciences
-
Boosting GWAS using biological networks: A study on susceptibility to familial breast cancerPLOS Computational Biology
-
-
-
Urinary Exosomes of Patients with Cystic Fibrosis Unravel CFTR-Related Renal DiseaseInternational Journal of Molecular Sciences
-
-
News
All news
-
The PR[AI]RIE institute, specializing in AI, obtains an endowment of €75 million and becomes PR[AI]RIE-PSAIIn 2019, Institut Curie participated in the creation of PR[AI]RIE, one of the four French artificial intelligence (AI) institutes born as part of the national initiative on AI announced by President Emmanuel Macron. The goal ? Revolutionize interdisciplinary research, training, and innovation in AI. Five years later, PR[AI]RIE, which is now among the world leaders in the sector, becomes PR[AI]RIE-PSAI (Paris School of AI) with a new endowment of €75 million from the AI Cluster program of the France 2030 plan and an emphasized approach to education and training.26/07/2024
-
L’Institut Curie engagé sur le front des cancers masculinsEn novembre, mois de sensibilisation aux cancers masculins, l’Institut Curie met en lumière les spécificités de ces cancers. Ses trois sites, Paris, Saint-Cloud et Orsay, offrent à chaque patient une prise en charge optimale des cancers de la prostate, des testicules et du pénis, ainsi qu’un accès à l’innovation. Côté recherche, les équipes s’intéressent aux aspects biologiques et physiologiques de ces maladies.03/11/2023
-
100% digital pathology at Institut CurieAll slides from tumor biopsies taken from new patients treated at Institut Curie are now digitized thanks to the work of the team at the Diagnostic and Theranostic Medicine Division (PMDT) at the Hospital Group.03/04/2023
-
Artificial intelligence for better diagnosis and thus better treatment for some types of breast cancersThe teams of Prof. Anne Vincent-Salomon and Prof. Thomas, from Institut Curie’s Hospital Group and Research Center respectively, in partnership with Mines Paris-PSL, have managed to train an artificial intelligence tool to predict a molecular anomaly using simple breast cancer histology samples. Their discovery was published in the prestigious scientific journal Cell Reports Medicine on December 13, 2022.19/12/2022
Partners